IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.

239 Updated and future aesthetic toxins
Saturday 03 February 2024
14:00 to 15:30
Amphi Havane - Level 3
聚焦课程

席位

Benjamin ASCHER 医师
整形外科医师
法国
Mark Steven NESTOR Prof
皮肤科医师
美国

讲座中的课程

14:00

Introduction

14:03

PART 1 - 2024 update on novel toxins

14:03

Update on Eirion’s topical and liquid injectable botulinum

14:12

PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus

14:21

Fast onset, long duration: “I want it all”? - Fastox

14:30

RelabotulinumtoxinA – Innovation From Lab to Clinic - Galderma

14:39

DaxibotulinumtoxinA: an update from Revance

14:48

Panel discussion

14:58

PART 2 - New toxins from Asia

14:58

The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong

15:08

New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel

15:18

Panel discussion & closing

15:28

Conclusion

推荐议程

遇到问题?

Discover IMCAS Academy

关注 IMCAS

需要帮助吗?

隐私政策 法律信息
© 2025 IMCAS - 国际医学美容抗衰老大师课程 版权所有。

错误

请填写所有必填字段。以下是缺失的字段: